VOYA Investment Management
CRVS icon

VOYA Investment Management’s Corvus Pharmaceuticals CRVS Stock Holding History

VOYA Investment Management’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Buy
123,379
+23,748
+24% +$330K ﹤0.01% 1273
2026
Q1 		$1.46M Buy
99,631
+71,970
+260% +$1.15M ﹤0.01% 1326
2025
Q4 		$213K Buy
+27,661
New +$218K ﹤0.01% 2125
2025
Q3 		– Sell
-14,774
Closed -$59.1K – 2489
2025
Q2 		$59.1K Buy
+14,774
New +$53.8K ﹤0.01% 2572

Other funds holding CRVS

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

VOYA Investment Management's CRVS Position: Q2 2026 in Review

VOYA Investment Management increased its Corvus Pharmaceuticals (CRVS) stake by 24% in Q2 2026, buying an estimated $330K and bringing the position to 123,379 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

VOYA Investment Management first reported a position in CRVS in Q2 2025 and has held it in 4 quarters since. 173 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.

  • VOYA Investment Management held 123,379 shares of Corvus Pharmaceuticals worth $1.84M as of Q2 2026.
  • VOYA Investment Management bought 23,748 Corvus Pharmaceuticals shares in Q2 2026, an estimated $330K.
  • Corvus Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1273 holding.
  • VOYA Investment Management first reported a position in Corvus Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 173 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.